Why is Vimedimex Medi-Pharma JSC ?
1
The company has declared Negative results for the last 6 consecutive quarters
- NET SALES(Q) At VND 241,273.85 MM has Fallen at -31.95%
- OPERATING PROFIT(Q) Lowest at VND 2,590.9 MM
- OPERATING PROFIT MARGIN(Q) Lowest at 1.07 %
2
Below par performance in long term as well as near term
- Along with generating -1.17% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Vimedimex Medi-Pharma JSC for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Vimedimex Medi-Pharma JSC
-0.88%
-0.07
31.42%
Vietnam VN Ho Chi Minh Index
29.95%
1.61
21.07%
Quality key factors
Factor
Value
Sales Growth (5y)
-42.82%
EBIT Growth (5y)
-61.18%
EBIT to Interest (avg)
4.28
Debt to EBITDA (avg)
0.52
Net Debt to Equity (avg)
-0.97
Sales to Capital Employed (avg)
11.12
Tax Ratio
23.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
71.81%
ROE (avg)
7.65%
Valuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.74
EV to EBIT
-60.17
EV to EBITDA
-3.15
EV to Capital Employed
-9.53
EV to Sales
-0.07
PEG Ratio
0.24
Dividend Yield
12.27%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
7.62%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
10What is working for the Company
NET PROFIT(HY)
At VND 18,248.86 MM has Grown at 74.24%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -14.05% (YoY
CASH AND EQV(HY)
Highest at VND 668,514.45 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -97.49 %
-13What is not working for the Company
NET SALES(Q)
At VND 241,273.85 MM has Fallen at -31.95%
OPERATING PROFIT(Q)
Lowest at VND 2,590.9 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 1.07 %
Here's what is working for Vimedimex Medi-Pharma JSC
Net Profit
At VND 18,248.86 MM has Grown at 74.24%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (VND MM)
Cash and Eqv
Highest at VND 668,514.45 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -97.49 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -14.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Vimedimex Medi-Pharma JSC
Net Sales
At VND 241,273.85 MM has Fallen at -31.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (VND MM)
Operating Profit
Lowest at VND 2,590.9 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (VND MM)
Operating Profit Margin
Lowest at 1.07 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales






